Addex Therapeutics Ltd (ADXN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
37
About the Report
About the Report
Summary
Addex Therapeutics Ltd (Addex) develops orally available, small molecule allosteric modulators for neurological disorders. The company's product pipeline consists of its lead products, dipraglurant (mGluR5 negative allosteric modulator or NAM) to treat Parkinson's disease levodopa-induced dyskinesia (PD-LID) and rare forms of dystonia; and ADX71149 (mGluR2 positive allosteric modulator or PAM) for the treatment of epilepsy. It also conducts clinical and preclinical development of drug candidates for indications such as addiction, Charcot-Marie-Tooth Type 1a (CMT1A) disease, spasticity in patients with multiple sclerosis (MS), pain, overactive bladder, autism and other disorders, Parkinson's disease, anxiety, resistant depression, cognitive deficits and psychosomatic disorders. Addex is headquartered in Plan-les-Ouates, Geneva, Switzerland.
Addex Therapeutics Ltd (ADXN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Addex Therapeutics Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
New Enterprise Associates and New Leaf Venture Partners Invest USD43 Million in Addex Therapeutics 10
Partnerships 12
Addex Therapeutics Enters into Partnership with National Institute on Alcohol Abuse and Alcoholism 12
Addex Therapeutics Enters into Partnership with National Institute on Drug Abuse 13
Addex Therapeutics And Viva Biotech Partner To Advance Allosteric Modulators Targeting Adenosine 2A Receptor 14
Addex Therapeutics Plans To Enter Into Co-Development Agreement For Dipraglurant 15
Licensing Agreements 16
Indivior Enters into Licensing Agreement with Addex Pharma 16
Pierre Fabre Pharma Enters into Licensing Agreement with Addex Therapeutics 17
Equity Offering 18
Addex Therapeutics Raises USD3 Million in Private Placement of Shares 18
Addex Therapeutics Raises Funds through Private Placement of Shares 19
Addex Therapeutics Raises USD2.8 Million in Private Placement of Shares 20
Addex Therapeutics Completes Private Placement Of Shares For USD 3.5 Million 21
Addex Therapeutics Completes Private Placement Of Shares For USD 11 Million 23
Addex Therapeutics Ltd-Key Competitors 24
Addex Therapeutics Ltd-Key Employees 25
Addex Therapeutics Ltd-Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
Sep 28, 2018: Addex reports 2018 half-year financial results and provides corporate update 27
Apr 30, 2018: Addex Announces 2017 Full Year Results 28
Sep 26, 2017: Addex Therapeutics Reports First Half 2017 Operating Highlights and Financial Results 30
Apr 05, 2017: Addex Therapeutics Provides Corporate Update and Reports 2016 Financial Results 31
Corporate Communications 32
Feb 07, 2018: Addex Appoints Jean-Philippe Rocher as Co-Head of Discovery and Member of the Executive Management 32
Sep 18, 2017: Addex Makes Changes to Executive Management Team 33
Product News 34
01/31/2017: Addex Awarded USD 835,000 Grant from Michael J. Fox Foundation to Advance TrkB PAMs for the Treatment of Parkinson's Disease 34
Other Significant Developments 35
Mar 20, 2018: Swiss Takeover Board Validates New Article 39 (Opting-Out Provision) of Addex Articles of Association 35
Mar 19, 2018: Addex Shareholders Approved all Board Proposals at Extraordinary General Meeting 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
List of Figure
List of Figures
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List of Table
List of Tables
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Addex Therapeutics Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
New Enterprise Associates and New Leaf Venture Partners Invest USD43 Million in Addex Therapeutics 10
Addex Therapeutics Enters into Partnership with National Institute on Alcohol Abuse and Alcoholism 12
Addex Therapeutics Enters into Partnership with National Institute on Drug Abuse 13
Addex Therapeutics And Viva Biotech Partner To Advance Allosteric Modulators Targeting Adenosine 2A Receptor 14
Addex Therapeutics Plans To Enter Into Co-Development Agreement For Dipraglurant 15
Indivior Enters into Licensing Agreement with Addex Pharma 16
Pierre Fabre Pharma Enters into Licensing Agreement with Addex Therapeutics 17
Addex Therapeutics Raises USD3 Million in Private Placement of Shares 18
Addex Therapeutics Raises Funds through Private Placement of Shares 19
Addex Therapeutics Raises USD2.8 Million in Private Placement of Shares 20
Addex Therapeutics Completes Private Placement Of Shares For USD 3.5 Million 21
Addex Therapeutics Completes Private Placement Of Shares For USD 11 Million 23
Addex Therapeutics Ltd, Key Competitors 24
Addex Therapeutics Ltd, Key Employees 25
Addex Therapeutics Ltd, Other Locations 26
Addex Therapeutics Ltd, Subsidiaries 26
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.